The nonsteroidal mineralocorticoid receptor antagonist finerenone has been reported to improve kidney and cardiovascular outcomes in persons with type 2 diabetes and chronic kidney disease (CKD).

Private equity firms have gained increasing control of U.S. health care infrastructure. Along with other potential consequences, this growth threatens to undermine progress in health equity.

The CMS Innovation Center is approaching the next negotiation cycle for the CGT Access Model. Several considerations will guide the selection of future candidate diseases and potential new model ...

Faced with a young woman whose seizures, of untraceable cause, can’t be stopped by the medical team, a medical student viscerally learns the limits to what can be accomplished by pushing harder.

A woman with asthma and obstructive sleep apnea presented with a 1-month history of worsening dyspnea and dry cough. CT of the chest showed anterior bowing of the posterior wall of the ...

Abstract To the Editor: In their article on the DREAMM-7 trial, Hungria and colleagues (Aug. 1 issue) 1 describe the treatment of patients with multiple myeloma that had progressed after at least one ...

Medical credit cards have emerged as a popular financing tool for patients seeking care they might otherwise be unable to afford. But these cards may ultimately increase financial burdens on patients.

The New England Journal of Medicine (NEJM) employs a media embargo system, which allows journalists time to conduct interviews in the days before an article’s publication. Qualified journalists ...

Welcome and thank you for considering the New England Journal of Medicine (NEJM) as a venue for your work. As the oldest continuously-published medical journal, our mission since 1812 has been to ...

NEJM.org features a vast array of content, dating back to 1812, with powerful capabilities for searching and finding just what you need. Search instructions and tips found below will help to ensure ...

Authors may complete the Presubmission Inquiry form below to learn about the suitability of proposed manuscripts or to propose review article topics. An NEJM Editor will generally respond by email ...